Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy (Q37817830)

23 August 2017

1 reference

title

Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy (English)

1 reference

23 August 2017

0 references

0 references

S Balachandar

1

1 reference

23 August 2017

A Katyal

series ordinal

2

1 reference

23 August 2017

publication date

9 December 2010

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

23 August 2017

published in

1 reference

23 August 2017

volume

30

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

483-498

1 reference

Dysregulation of coagulation in cerebral malaria.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

The role of platelets in the pathogenesis of cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Erythrocytic casein kinase II regulates cytoadherence of Plasmodium falciparum-infected red blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

CD44, a signal receptor for the inhibition of the cytoadhesion of CD36-binding Plasmodium falciparum-infected erythrocytes by CSA-binding infected erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Neural cell adhesion molecule, a new cytoadhesion receptor for Plasmodium falciparum-infected erythrocytes capable of aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

The role of tumour necrosis factor-alpha in the pathogenesis of complicated falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

The guanylhydrazone CNI-1493: an inhibitor with dual activity against malaria-inhibition of host cell pro-inflammatory cytokine release and parasitic deoxyhypusine synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Triclosan inhibit the growth of the late liver-stage of Plasmodium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

The Role of PPARs in MDR - a lesson from embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Activation of peroxisome proliferator-activated receptor-gamma by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Tumor necrosis factor ? in the pathogenesis of cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Cytoadherence between endothelial cells and P. falciparum infected and noninfected normal and thalassemic red blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

High-level cerebellar expression of cytokines and adhesion molecules in fatal, paediatric, cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Evidence of blood-brain barrier dysfunction in human cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Cerebral malaria: role of microparticles and platelets in alterations of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Possible central role of nitric oxide in conditions clinically similar to cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Statins fail to improve outcome in experimental cerebral malaria and potentiate Toll-like receptor-mediated cytokine production by murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Genetic characterization and evolutionary inference of TNF-alpha through computational analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

TNF family members and malaria: old observations, new insights and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Plasmodium falciparum adhesion on human brain microvascular endothelial cells involves transmigration-like cup formation and induces opening of intercellular junctions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

The adhesion molecule ICAM-1 and its regulation in relation with the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Role of ICAM-1 (CD54) in the development of murine cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Plasmodium falciparum-infected erythrocytes bind ICAM-1 at a site distinct from LFA-1, Mac-1, and human rhinovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Pathogenic T cells in cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Inhibition of endothelial activation: a new way to treat cerebral malaria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Expression of major histocompatibility complex antigens on mouse brain microvascular endothelial cells in relation to susceptibility to cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Neutrophils play a critical role in the pathogenesis of experimental cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Cytokine and chemokine mRNA expression in neutrophils from CBA/NSlc mice infected with Plasmodium berghei ANKA that induces experimental cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Role of neutrophil-endothelial cell adhesion in inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Brain macrophage activation in murine cerebral malaria precedes accumulation of leukocytes and CD8+ T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Glial activation and matrix metalloproteinase release in cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Increased eosinophil activity in acute plasmodium falciparum infection - association with cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

The eosinophilic response and haematological recovery after treatment for Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

The importance of T cell homing and the spleen in reaching a balance between malaria immunity and immunopathology: the moulding of immunity by early exposure to cross-reactive organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Immunopathogenesis of cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Induction of blood brain barrier tight junction protein alterations by CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Early activation of microglia in the pathogenesis of fatal murine cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Redox-dependent apoptosis in human endothelial cells after adhesion of Plasmodium falciparum-infected erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Evidence for the role of peroxisome proliferator-activated receptor-beta/delta in the development of spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Increased plasma levels of histidine and histamine in falciparum malaria: relevance to severity of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Seventy-five years of Resochin in the fight against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Treatment of malaria--1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Artemisone effective against murine cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Immunomodulatory therapy associated to anti-parasite drugs as a way to prevent severe forms of malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

An edible vaccine for malaria using transgenic tomatoes of varying sizes, shapes and colors to carry different antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

History, dynamics, and public health importance of malaria parasite resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Return of chloroquine antimalarial efficacy in Malawi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Cardiotoxicity of antimalarial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

The safety of antimalarial drugs in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Case report: combination artemether-lumefantrine and haemolytic anaemia following a malarial attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Chorea in a 29-year-old Nigerian following antimalarial treatment with artesunate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Quinine-induced renal bilateral cortical necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Antimalarial drugs in pregnancy: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

PPARs: diverse regulators in energy metabolism and metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

PPARs in diseases: control mechanisms of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

The mechanisms of action of PPARs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

PPAR-alpha expression inversely correlates with inflammatory cytokines IL-1beta and TNF-alpha in aging rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

PPAR-alpha activators suppress STAT1 inflammatory signaling in lipopolysaccharide-activated rat glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Cortical expression of peroxisome proliferator-activated receptor-alpha after human brain contusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Peroxisome proliferator-activated receptor gamma-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-alpha secretion by monocytes/macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Brain endothelial PPARgamma controls inflammation-induced CD4+ T cell adhesion and transmigration in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Rosiglitazone alone or in combination with tissue plasminogen activator improves ischemic brain injury in an embolic model in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic Agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

The PPAR-gamma agonist, darglitazone, restores acute inflammatory responses to cerebral hypoxia-ischemia in the diabetic ob/ob mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

PPAR-gamma, Microglial Cells, and Ocular Inflammation: New Venues for Potential Therapeutic Approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

PPARgamma as a therapeutic target in central nervous system diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Modulation of transcription by the peroxisome proliferator-activated receptor delta--binding RNA aptamer in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Activation of PPARbeta/delta inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Essential role of Smad3 in the inhibition of inflammation-induced PPARbeta/delta expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

A PPARdelta agonist reduces amyloid burden and brain inflammation in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARbeta/delta ligand GW0742.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

PPARdelta ligand L-165041 ameliorates Western diet-induced hepatic lipid accumulation and inflammation in LDLR-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Peroxisome proliferator-activated receptor {delta} regulates extracellular matrix and apoptosis of vascular smooth muscle cells through the activation of transforming growth factor-{beta}1/Smad3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

PPARdelta status and Apc-mediated tumourigenesis in the mouse intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Peroxisome proliferator-activated receptor (PPAR) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

PPARalpha activators may be good candidates as antiaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

The role of herbal PPAR modulators in the treatment of cardiometabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1122-9

Routine anticonvulsants for treating cerebral malaria.

21 January 2018

1 reference

12 December 2020

Modulation of cerebral malaria by fasudil and other immune-modifying compounds

1 reference

12 December 2020

Evidence of Artemisinin-Resistant Malaria in Western Cambodia

1 reference

12 December 2020

Phagocytosis of haemozoin (malarial pigment) enhances metalloproteinase-9 activity in human adherent monocytes: role of IL-1beta and 15-HETE.

1 reference

12 December 2020

Ventricular fibrillation in a 5-year-old child on therapeutic dose of quinine dihydrochloride infusion for acute malaria.

1 reference

12 December 2020

Tumor necrosis factor-alpha expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes.

1 reference

12 December 2020

Strain variation in tumor necrosis factor induction by parasites from children with acute falciparum malaria

1 reference

12 December 2020

Killing of Plasmodium falciparum by eosinophil secretory products.

1 reference

12 December 2020

Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.

1 reference

12 December 2020

PPARdelta is a type 1 IFN target gene and inhibits apoptosis in T cells

1 reference

12 December 2020

Safety of epoietin beta-quinine drug combination in children with cerebral malaria in Mali

1 reference

12 December 2020

Headache and malaria: a brief review

1 reference

12 December 2020

Effect of intravenous quinine on capillary glucose levels in malaria.

1 reference

12 December 2020

Role of PPARs in Radiation-Induced Brain Injury

1 reference

12 December 2020

Nanotechnology applied to the treatment of malaria

1 reference

12 December 2020

Efficacy and safety of quinine-artesunate in an HIV-positive patient with severe falciparum malaria.

1 reference

12 December 2020

Extrapyrbmidal syndrome following chloroquine therapy

1 reference

12 December 2020

Canadian recommendations for the prevention and treatment of malaria among international travellers. Committee to Advise on Tropical Medicine and Travel (CATMAT)

1 reference

12 December 2020

An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration.

1 reference

12 December 2020

Endothelin in a murine model of cerebral malaria

1 reference

12 December 2020

Role of the tumor necrosis factor receptor 2 (TNFR2) in cerebral malaria in mice.

1 reference

12 December 2020

Effects of the PPAR-beta agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination

1 reference

12 December 2020

Case report: Retinopathy after malaria prophylaxis with chloroquine

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment.

1 reference

12 December 2020

Peroxisome Proliferator-Activated Receptor beta/delta in the Brain: Facts and Hypothesis

1 reference

12 December 2020

Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta

1 reference

12 December 2020

Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study

1 reference

12 December 2020

Chlorproguanil-dapsone for treating uncomplicated malaria

1 reference

12 December 2020

Cutting edge: distinct roles for T help and CD40/CD40 ligand in regulating differentiation of proliferation-competent memory CD8+ T cells

1 reference

12 December 2020

Atovaquone-proguanil for treating uncomplicated malaria

1 reference

12 December 2020

Peroxisome proliferator-activated receptor delta agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis

1 reference

12 December 2020

Iron-chelating agents for treating malaria

1 reference

12 December 2020

Retinopathy due to 4-aminoquinolines in the prevention of malaria

1 reference

12 December 2020

Resistance to cerebral malaria in tumor necrosis factor-alpha/beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response

1 reference

12 December 2020

Surface molecules on Plasmodium falciparum-infected erythrocytes involved in adherence

1 reference

12 December 2020

Neurotoxicity and artemisinin compounds do the observations in animals justify limitation of clinical use?

1 reference

12 December 2020

Exploring novel targets for antimalarial drug discovery: plasmodial protein kinases

1 reference

12 December 2020

Transporters as mediators of drug resistance in Plasmodium falciparum

1 reference

12 December 2020

PPARdelta-mediated macrophage activation: a matter of fat

1 reference

12 December 2020

1 reference

12 December 2020

Targeting Plasmodium falciparum purine salvage enzymes: a look at structure-based drug development

1 reference

12 December 2020

Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice study

1 reference

12 December 2020

10.1007/S10096-010-1122-9

Identifiers

DOI

1 reference

23 August 2017

1 reference